Skip to main content
SERA logo

SERA · Sera Prognostics, Inc. · Metrics

Track SERA — free
$2.03 -0.02 (-0.98%) At close · Sep 11
Market Cap
$80.08M
Shares
39.45M

SERA metrics

66 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.03
Market cap
$80.08M

Price action

20 metrics
Price change (1W)
+0.5%
Price change (30D)
+3.6%
Price change (3M)
+8.6%
Price change (6M)
-4.7%
Price change (YTD)
-31.2%
Price change (1Y)
-33.9%
Trailing year
Price change (5Y)
-79.4%
52-week high
$3.75
52-week low
$1.59
Change from 52-week high
-45.9%
Change from 52-week low
+27.7%
Annualized volatility
72.4%
Annualized volatility (3M)
60.1%
Beta
0.9
RSI (14D)
49.1
Price vs SMA 50
-1.0%
Price vs SMA 200
-13.8%
Avg volume (3M)
34,095
Relative volume
0.8
Average dollar volume
$68,209

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
39.45M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
1,144.0×
reciprocal yield 0.1%
P / book
1.3
reciprocal yield 74.1%
FCF yield
-35.1%
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield
-41.5%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
-150.0%
Operating margin
-53,282.9%
Trailing 12 months
Net margin
-47,475.7%
Gross profit (TTM)
Operating profit (TTM)
−$37.30M
Net income (TTM)
−$33.23M
Trailing 12 months
Diluted EPS (TTM)
$-0.66
FCF margin
-40,211.4%
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share

Growth

11 metrics
Revenue growth YoY
+76.5%
Year over year
Net income growth YoY
Revenue (TTM)
$70,000
Trailing 12 months
EPS growth YoY
Shares change YoY
+2.9%
Year over year · more shares
Revenue CAGR (3Y)
-32.9%
Revenue CAGR (5Y)
+26.5%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
-56.0%
Return on assets
-38.3%
Debt / equity
Current ratio
2.0
EBITDA (TTM)
−$36.43M
Free cash flow (TTM)
−$28.15M
Quick ratio
2.0
Interest coverage
-5,328.3
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
$46.45M
Latest balance sheet
Cash & equivalents
$4.40M
Total assets
$86.74M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$27.68M
Capital expenditures (TTM)
$466,000
R&D (TTM)
$13.02M
SG&A (TTM)
Stock compensation (TTM)
$3.93M
R&D / revenue
18,604.3%
Stock compensation / revenue
5,615.7%

Ownership (13F)

3 metrics
13F filers
46
13F filer change QoQ
-10
Institutional ownership
43.2%

Short interest

3 metrics
Short interest
0.6%
Latest settlement · 10.5 days to cover
Days to cover
10.5d
Short-squeeze score
62 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$63,274
Insider-sentiment score
31 / 100

Risk flags

1 metrics
Going concern
Key facts CIK 1534969 CUSIP 81749D107 13F (30d) 13 filings 13 filers Visit website Investor relations